1-9 of 9
Weiqing Jing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Gut Microbiome Regulates FVIII Immune Responses

Weiqing Jing, Jocelyn Schroeder, Yuanhua Cai, Jennifer Ziegelbauer, Mary Holtz, Nita Salzman, Qizhen Shi
Journal: Blood
Blood (2024) 144 (Supplement 1): 2575.
https://doi.org/10.1182/blood-2024-211271
Published: 2024
Journal Articles

The Tfh/Tfr Pathway Is Pivotal in FVIII Inhibitor Development in Mice

Weiqing Jing, Jocelyn Schroeder, Juan Chen, Yuanhua Cai, Saurabh Kumar, Alexander Dent, Qizhen Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3971.
https://doi.org/10.1182/blood-2023-180998
Published: 2023
Journal Articles

Pre-Existing Anti-FVIII Immunity Alters Therapeutic Platelet-Targeted FVIII Engraftment in the System Preconditioned with Busulfan Alone through Cytotoxic CD8 T Cells

Weiqing Jing, Christina Baumgartner, Feng Xue, Jocelyn A. Schroeder, Qizhen Shi
Journal: Blood
Blood (2021) 138 (Supplement 1): 444.
https://doi.org/10.1182/blood-2021-153722
Published: 2021
Journal Articles

Induction of Activated T Follicular Helper Cells Is Critical for Anti-FVIII Inhibitor Development in Hemophilia a Mice

Weiqing Jing, MD PhD, Juan Chen, PhD, Yuanhua Cai, MD, Yingyu Chen, PhD, Jocelyn A. Schroeder, Weiguo Cui, MD PhD, Qizhen Shi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 92.
https://doi.org/10.1182/blood-2019-123777
Published: 2019
Journal Articles

Fludarabine in Combination with Busulfan As Pretransplant Conditioning for Platelet Gene Therapy in Murine Hemophilia a with Inhibitors

Yingyu Chen, PhD, Jing Li, MD PhD, Jocelyn A. Schroeder, Weiqing Jing, MD PhD, Jianda Hu, PhD, Qizhen Shi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1108.
https://doi.org/10.1182/blood-2019-127410
Published: 2019
Journal Articles

Depletion of CD25 + T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma

Weiqing Jing, Xiaocai Yan, William H. D. Hallett, Jill A. Gershan, Bryon D. Johnson
Journal: Blood
Blood (2011) 117 (25): 6952–6962.
https://doi.org/10.1182/blood-2010-12-326108
Published: 2011
Includes: Supplemental data
Journal Articles

Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory

Weiqing Jing, Jill A. Gershan, Bryon D. Johnson
Journal: Blood
Blood (2009) 113 (18): 4449–4457.
https://doi.org/10.1182/blood-2008-11-190827
Published: 2009
Includes: Supplemental data
Journal Articles

Vaccine-Induced Anti-Neuroblastoma Immunity Early after HSCT Arises in the Presence of Foxp3 + CD25 + CD4 + T Cells.

Weiqing Jing, PhD, Rimas J. Orentas, Ph.D, Bryon D. Johnson, Ph.D
Journal: Blood
Blood (2006) 108 (11): 3692.
https://doi.org/10.1182/blood.V108.11.3692.3692
Published: 2006
Journal Articles

Induction of Tumor Immunity Early after Syngeneic Bone Marrow Transplantation (BMT) by Transient Transfection of Mouse Neuroblastoma with Plasmid DNA Vectors Encoding a Panel of Immune Stimulatory Molecules.

Weiqing Jing, Rimas J. Orentas, Bryon D. Johnson
Journal: Blood
Blood (2005) 106 (11): 1308.
https://doi.org/10.1182/blood.V106.11.1308.1308
Published: 2005